Universität zu Köln

Journal Article

Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A., Zijlstra, Josee M., Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Huttmann, Andreas ORCID: 0000-0003-2230-3873, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S., Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kuhnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus and Engert, Andreas (2017). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390 (10114). S. 2790 - 2803. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Borchmann, Peter, Haverkamp, Heinz, Lohri, Andreas, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Engel, Nicole, Keller, Ulrich, Maschmeyer, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2014). Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Engert, Andreas, Kobe, Carsten, Haverkamp, Heinz, Kuhnert, Georg, Markova, Jana, Lohri, Andreas, Klutmann, Susanne, Amthauer, Holger, Diehl, Volker, Borchmann, Peter and Dietlein, Markus (2012). Relative Reduction of Residual Tumor Improves Outcome Prediction of PET After Effective Chemotherapy for Patients with Advanced Stage Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Eich, Hans, Baues, Christian, Greil, Richard, Sasse, Stephanie, Zijlstra, Josee M., Lohri, Andreas, Rosenwald, Andreas, von Tresckow, Bastian, Diehl, Volker, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kreissl, Stefanie, Goergen, Helen, von Tresckow, Bastian, Behringer, Karolin, Markova, Jana, Lohri, Andreas, Meissner, Julia, Zijlstra, Josee M., Greil, Richard, Topp, Max S., Soekler, Martin, Doehner, Hartmut, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2015). Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rothe, Achim, Sasse, Stephanie, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Jaeger, Ulrich, Bangard, Christopher and Engert, Andreas (2012). Brentuximab Vedotin (SGN-35) in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies without Prior High-Dose Chemotherapy and Stem Cell Transplantation. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Sasse, Stephanie, Rothe, Achim, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Kreher, Stephan, Jaeger, Ulrich, Bangard, Christopher, Kuhnert, Georg, Boell, Boris, von Tresckow, Bastian and Engert, Andreas (2013). Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma. Leuk. Lymphoma, 54 (10). S. 2144 - 2149. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194